What is the market timing theory of capital structure, and what evidence supports the idea that firms time equity issuance?
For CFA corporate finance, I need to understand the market timing theory alongside trade-off and pecking order. The claim is that firms issue equity when their stock is overvalued. How does this differ from pecking order, and what's the empirical basis?
The market timing theory (Baker and Wurgler, 2002) proposes that capital structure is not the result of an optimal target or a financing hierarchy, but rather the cumulative outcome of past attempts to time the equity market. Firms issue equity when their stock appears overvalued and repurchase equity (or issue debt) when it appears undervalued.\n\nKey Distinction from Pecking Order:\n\n- Pecking order: Firms avoid equity because of adverse selection costs (the market assumes equity issuers are overvalued)\n- Market timing: Firms deliberately exploit perceived overvaluation to issue equity at favorable prices\n\nThe information asymmetry is similar, but the behavioral implication differs: pecking order says firms reluctantly issue equity; market timing says firms strategically issue equity.\n\nEmpirical Evidence:\n\n1. Market-to-book ratio predicts issuance: Firms with high market-to-book ratios (suggesting overvaluation) are significantly more likely to issue equity. The relationship is strong and robust across time periods and countries.\n\n2. Long-run underperformance after SEOs: Firms that issue seasoned equity tend to underperform the market by 3-5% annually over the subsequent 3-5 years, consistent with issuance occurring at inflated prices.\n\n3. IPO cycles: Initial public offerings cluster during bull markets and \"hot\" IPO windows. The volume of IPOs is strongly correlated with market valuations, suggesting systematic timing.\n\n4. Survey evidence: Graham and Harvey (2001) surveyed CFOs and found that two-thirds reported that the amount their stock is undervalued or overvalued is an important consideration in equity issuance decisions.\n\n5. Persistent effects on leverage: Baker and Wurgler showed that a firm's current leverage ratio is strongly explained by its historical market-to-book ratios, even controlling for current characteristics. High market-to-book periods leave lasting low-leverage imprints.\n\nWorked Example:\n\nCardwell Biotech has the following financing history:\n\n| Year | Market/Book | Financing Action | Effect on Leverage |\n|---|---|---|---|\n| 2020 | 1.2x | Issued $30M in bonds | Leverage increased |\n| 2021 | 3.5x | Issued $80M in equity (stock at all-time high) | Leverage decreased sharply |\n| 2022 | 1.8x | Retained earnings, no issuance | Leverage drifted slightly |\n| 2023 | 1.0x | Repurchased $25M in stock | Leverage increased |\n| 2024 | 2.8x | Issued $50M convertible preferred | Leverage decreased |\n\nCardwell's current leverage reflects the accumulated history of market timing decisions rather than convergence toward any target ratio.\n\nCriticisms:\n\n- Rational expectations models suggest persistent mispricing is unlikely in efficient markets\n- The evidence could reflect growth opportunities (high M/B = high investment needs) rather than deliberate timing\n- If all firms time the market, the aggregate effect should net to zero\n- Managers may believe they are timing the market but may simply be responding to investor demand\n\nSynthesis:\nMarket timing likely plays a role alongside trade-off and pecking order considerations. Firms may have target ranges (trade-off), prefer internal funds (pecking order), but also adjust timing and security choice based on market conditions (market timing).\n\nExplore all three capital structure theories in our CFA Corporate Finance course.
Master Level II with our CFA Course
107 lessons · 200+ hours· Expert instruction
Related Questions
What are the most reliable candlestick reversal patterns, and how should CFA candidates interpret them in context?
What are the CFA Standards requirements for research reports, and what must be disclosed versus recommended?
How does IAS 41 require biological assets to be measured, and what happens when fair value cannot be reliably determined?
Under IFRIC 12, how should a company account for a service concession arrangement, and what determines whether the intangible or financial asset model applies?
What is the investment entities exception under IFRS 10, and why are some parents exempt from consolidating their subsidiaries?
Join the Discussion
Ask questions and get expert answers.